INTRODUCTION
Meconium is a thick greenish black stuff holding various types of cells along with mucus, water, digestive acids and enzymes. The word meconium is derivative from Greek expression mekonion. 1 Meconium constitutes the 1 st stool of a newborn. The passage of meconium happens within 48 hours following birth, though, it can occur in utero. Post-term fetus usually passes the meconium physiologically. Intrauterine meconium passage is connected with fetomaternal stress and preterm pregnencies. 2 In term and post-term newborns devoid of fetal distress, intrauterine meconium passage occurs from usual GI flourishing. Meconium staining of the amniotic fluid emerges in ~13% of live births that augments with rising gestational age. 3 MAS is linked with notable respiratory morbidity, 4 characterized by early inception of respiratory distress in a meconium stained infant coupled with poor lung compliance and hypoxemia, clinically and patchy opacification, and radiographically visible PTX. Intubation and mechanical ventilation is needed in more than 30% of infants with MAS along with many other modern therpies. 6, 7 Numerous perinatal risk factors have been related with MAS including placental insufficiency, maternal hypertension, maternal diabetes mellitus, pre-eclampsia, oligohydramnios and maternal tobacco use. 8, 9 Post-term delivery is described as the most significant risk factor. According to Yoder BA et al, MAS lowered from 6% to <2% in an eight year duration through decline in births at>41 weeks gestation. 10 Spectrum of MAS varies from mild to severe. 11 Reduction in the incidence of MAS have been reported globally, [12] [13] [14] credited to improved obstetric practices and prompt delivery where fetal distress found. 15, 16 It is obvious that severe MAS is allied with high risk of PTX, longer duration of respiratory supports and oxygen therapy. Variation in mortality rates related to PTX have been observed ranging from 5% to 35%. 16 Marked differences in published figures are recognized related to problems identifying the cause of mortality. 16 PTX is a significant indicator of disease severity, accounting to 42% of infants who eventually died of MAS. 8 Sindhu et al noted the frequency of PTX as 25% in neonates having MAS. 17 PTX in newborn from any cause can be a concern for later lung diseases. [15] [16] [17] As PTX in pediatric population is increasing and available stats of PTX in newborn with MAS are very scarce, so, this study was planned to be a useful addition in the existing literature and help the clinicians to take further steps in managing these particular patients in order to improve their outcome.
MATERIALS AND METHODS

Department of Pediatric Medicine, Unit 1, Bahawal
Victoria Hospital, Bahawalpur, and department of Pediatric Medicine, Ghazi Khan Medical College/ Hospital, Dera Ghazi Khan, were the venues for this descriptive, cross-sectional study, done spanning 1 st June 2017 to 30 th September 2018. A total of 736 neonates (age 1 to 28) days, of both genders, with MAS (infant's skin, umbilical cord, or nail beds was of green color on clinical examination and diffuse 'wet' crackles and rhonchi on auscultation) were included in the study using non-probability, consecutive sampling. All neonates were excluded who were preterm (<37 weeks of gestation) or had congenital heart anomalies as assessed on echocardiography.
Approval from ethical review committee of the institution was taken. Written informed consent was taken from the parents / guardians. Presence or absence of pneumothorax in each patient was noted. All data including age, gender, weight of infant, mode of delivery, gestational diabetes mellitus, pregnancy induced hypertension, place of living and PTX were noted. Age, birth weight, weight and height were presented as mean and standard deviation. The frequency of pneumothorax (yes/no), gender, residence (rural/ urban), birth weight, mode of delivery (vaginal/ cesarean), gestational diabetes mellitus (yes/no) and pregnancy induced hypertension (yes/no) were calculated. Stratification was performed to control effect modifier like age, gender, residence (rural/urban), birth weight, mode of delivery (vaginal/cesarean), gestational diabetes mellitus (yes/no) and pregnancy induced hypertension (yes/no). The Chi square test was applied to see the effect of these on outcome variable i.e. pnumothorax. P value ≤0.05 was taken as significant.
RESULTS
Age range in this study was from 1 to 28 days with mean age of 12.80 ± 6.52 days. Majority of the patients 434 (58.97%) were between 1 to 14 days of age as shown in Table I .
Out of the 736 patients, 394 (53.53%) were male and 342 (46.47%) were females with male to female ratio of 1.2:1. There were 290 (39.40%) neonates who belonged to urban areas whereas 446 (60.60%) to rural areas. A total of 412 (55.98%) neonates were delivered using vaginal delivery while 324 (44.02%) with cesarean. Mean birth weight was 3.09 ± 0.40 kg. Mean height was 38.41 ± 5.33 cm. Pregnancy induced hypertension was noted in 546 (74.2%) while GDM 452 (61.4%). Frequency of pneumothorax in newborn with meconium aspiration was found in 176 (23.91%) patients, whereas there was no pneumothorax in 560 (76.09%) patients as shown in Figure-1 . When stratification of pneumothorax was done, it showed no significant different (P >0.05) with respect to age groups, gender, area of residence mode of delivery, birth weight, PIH and GDM as shown in Table- I. 
DISCUSSION
Neonates are most commonly affected by PTX in comparison to any other age groups. 18 Symptomatic PTX is visible in 0.1% of all live births and in 5-7% of newborns having birth weight<1500 grams. 19, 20 Continuous positive airway pressure and positive pressure ventilation are known to pronounce PTX. 19, 20 Surfactant, synchronize or volume ventilation, and highrate, low-tidal-volume ventilation lower the incidence of PTX. [21] [22] [23] [24] PTX needs to be scrutinized in all newborns who have respiratory distress, restlessness and/or have a sudden change in condition.
Age range in this study was from 1 to 28 days with mean age of 12.80 ± 6.52 days. 17 The prevalence of PTX has been noted as 25% in 2001 and around 10% in 2009, 25, 26 the former is closer to the present figures (23.64%).
PTX in NICU is reported as 1-2% and >40% if respiratory distress syndrome (RDS) is present. [27] [28] [29] [30] Mortality rates have varied from 20-38%. 31 Contributing factors in the NICU are male gender, LBW neonates, prematurity, birth by cesarean section, RDS, and MAS needing resuscitation following birth. 32 PTX in newborn intensifies chronic lung disease in VLBW neonates [33] [34] [35] and intraventricular hemorrhage in pre-term neonates. 36 Watkinson and Tiron 37 noted that 9% ventilated neonates went on to develop at least one PTX during the 1 st 2-weeks of life. A higher incidence of upto 13% was reported from UK 38, 39 and 26% by Malek and colleagues from Iran. 40 Morley et al 41 got incidence of PTX as 9% after CPAP. PTX was found in 11% VLBW infants in another 5-years study. 34, 42 Razzaq et al 43 noted the prevalence of PTX in infants with MAS as 13% while Greenboughet et al got higher numbers, nearly 33%. Our study differs from these data, less use of mechanical ventilation could be the reason behind this as mechanical ventilation is known to be a common risk factor for development of pneumothorax. 45, 46 Underlying lung pathology was a cause of pneumothorax in neonates rather than being a complication of mechanical ventilation when noted by Esme and coworkers. 47 
